logo

For the Inventor, By the Inventor

Osaka, Japan

Sumitomo Dainippon Pharma Co., Ltd.


USPTO Granted Patents = 110



Trademarks = 32

Forward Citations = 692

Loading Chart...
Loading Chart...

207 inventors (with patents filed for the assignee):

goldMedal Hitoshi Ban (16 out of 37 patents)

silverMedal Hidefumi Yoshinaga (9 out of 18 patents)

bronzeMedal Futoshi Hasegawa (7 out of 12 patents)

4.  Seiji Kamioka (6 out of 14 patents)

5.  Izumi Sasaki (6 out of 8 patents)

6.  Yoko Takahashi (6 out of 13 patents)

7.  Yoshiaki Isobe (6 out of 28 patents)

8.  Kazuki Hashimoto (5 out of 21 patents)

9.  Chiang Jia Li (5 out of 57 patents)

10.  Tomohiro Toyoda (5 out of 11 patents)

11.  Itaru Natsutani (5 out of 7 patents)

12.  Daisuke Urabe (5 out of 6 patents)

13.  Hidenori Kimura (5 out of 11 patents)

14.  Yohei Ikuma (5 out of 12 patents)

15.  Yosuke Takanashi (5 out of 10 patents)


Core Competencies:
Optically Active Azabicyclo Ring Derivative
Cycloalkylurea Derivative
Malaria Vaccine
Anticancer Agent
Vaccine Adjuvant Formulation
Deuterated Benzimidazole Compound
Substituted Pyrimidines
Therapeutic Agent for Fibrodysplasia
Substituted Pyrazolo Compounds
Medicinal Chemistry
Pharmaceutical Composition for Injection
Bicyclic Heterocyclic Amide Derivative

110 patents:

1. 11369605 - Optically active azabicyclo ring derivative (2022-06-28),
2. 11352366 - 2-aminoquinazolinone derivative (2022-06-07),
3. 11352357 - Cycloalkylurea derivative (2022-06-07),
4. 11339151 - Aliphatic acid amide derivative (2022-05-24),
5. 11325921 - Optically active crosslinked cyclic secondary amine derivative (2022-05-10),
6. 11312688 - Pyrazole compound (2022-04-26),
7. 11299465 - Carboxylic acid compounds (2022-04-12),
8. 11273212 - Malaria vaccine (2022-03-15),
9. 11267797 - Anticancer agent (2022-03-08),
10. 11266738 - Substituted pyrimidines as vaccine adjuvants (2022-03-08),
11. 11253476 - Vaccine adjuvant formulation (2022-02-22),
12. 11242332 - Method for producing benzimidazole derivative (2022-02-08),
13. 11214772 - Production method for retinal tissue (2022-01-04),
14. 11214771 - Production method for nerve tissue (2022-01-04),
15. 11207303 - Therapeutic agent for fibrodysplasia ossificans progressiva (2021-12-28),
Sumitomo Dainippon Pharma Co., Ltd. is a pharmaceutical company based in Japan. They are engaged in research, development, manufacturing, and marketing of various drugs and therapeutics. With a focus on psychiatric and neurological disorders, they strive to contribute to the well-being of people by providing innovative solutions for healthcare. For more information, visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

110 Patents

#104 in Osaka

#1,035 in Japan

#6,965 in the World

...
Osaka, Japan

Sumitomo Dainippon Pharma Co., Ltd.

Forward Citations = 692

207 inventors:

goldMedal Hitoshi Ban (16 out of 37 patents)

silverMedal Hidefumi Yoshinaga (9 out of 18 patents)

bronzeMedal Futoshi Hasegawa (7 out of 12 patents)

4.  Seiji Kamioka (6 out of 14 patents)

5.  Izumi Sasaki (6 out of 8 patents)

Please report any incorrect information to support@idiyas.com
Loading…